Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 775 of 866 entries
View as:

Flexible-Dose, Adjunctive Therapy Trial in Adults With Parkinson's Disease With Motor Fluctuations (TEMPO-3)

Phase: N/A Priority: Normal
NCT ID: NCT04542499 Org: User:
Start: 09/23/20 End: 02/15/24 Due: 02/15/25

Extension Trial Assessing the Safety and Efficacy of BI 655066/ABBV-066/Risankizumab in Patients With Moderate to Severe Chronic Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT02203851 Org: User:
Start: 11/20/14 End: 09/04/18 Due: 09/04/19

A Study to Assess Change in Disease Activity, Adverse Events, and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion or Subcutaneous (SC) Injection of Budigalimab and/or ABBV-382

Phase: N/A Priority: Normal
NCT ID: NCT06032546 Org: User:
Start: 10/12/23 End: 03/31/27 Due: 03/31/28

Concomitant Longitudinal Evaluation of Adalimumab With Methotrexate in the Real World: the CLEAR Study

Phase: N/A Priority: Normal
NCT ID: NCT02196701 Org: User:
Start: 08/05/14 End: 03/17/17 Due: 03/17/18

A Study to Evaluate Sequential Administration of AGN-151586 and OnabotulinumtoxinA (BOTOX) Injections in Adult Participants for Treatment of Glabellar Lines

Phase: N/A Priority: Normal
NCT ID: NCT05496335 Org: User:
Start: 08/30/22 End: 05/30/23 Due: 05/30/24

Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women

Phase: N/A Priority: Normal
NCT ID: NCT02654054 Org: User:
Start: 12/22/15 End: 12/12/18 Due: 12/12/19

Study Evaluating Duvelisib in Japanese Subjects With Relapsed or Refractory Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT02598570 Org: User:
Start: 11/30/15 End: 02/28/17 Due: 02/28/18

A Study to Evaluate ABT-494 (Upadacitinib) in Adults With Moderate to Severe Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT02925117 Org: User:
Start: 10/25/16 End: 01/31/19 Due: 01/31/20

A Study to Assess Safety and Effectiveness of HArmonyCa Lidocaine Injectable Gel for Restoration and/or Creation of Mid-Face Volume in Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT07032597 Org: User:
Start: 05/26/25 End: 10/31/26 Due: 10/31/27

First in Human Study of IMGN151 in Recurrent Gynaecological Cancers

Phase: N/A Priority: Normal
NCT ID: NCT05527184 Org: User:
Start: 01/11/23 End: 02/28/27 Due: 02/28/28

Study To Assess Adverse Events and Change in Disease Activity Of 24-hour Continuous Subcutaneous Infusion Of ABBV-951 In Adult Participants With Advanced Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT04750226 Org: User:
Start: 02/18/21 End: 04/01/26 Due: 04/01/27

Observational Study of Adult Participants With Diabetic Macular Edema and Suboptimal Response to Anti-Vascular Endothelial Growth Factor Treated With Dexamethasone Intravitreal Implant

Phase: N/A Priority: Normal
NCT ID: NCT05978622 Org: User:
Start: 10/30/23 End: 06/30/26 Due: 06/30/27

A Study to Assess the Adverse Events and How Subcutaneous (SC) Injections and Intravenous (IV) Infusions of ABBV-142 Move Through the Body of Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT06774313 Org: User:
Start: 01/22/25 End: 12/31/25 Due: 12/31/26

A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD)

Phase: N/A Priority: Normal
NCT ID: NCT04064827 Org: User:
Start: 09/16/20 End: 10/31/26 Due: 10/31/27

An Observational Study to Assess Change in Disease Activity and Treatment Patterns of Upadacitinib When Given Alone or Co-Administered With Methotrexate in Adult Participants With Active Psoriatic Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT05616871 Org: User:
Start: 12/15/22 End: 07/31/27 Due: 07/31/28

Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD

Phase: N/A Priority: Normal
NCT ID: NCT04704921 Org: User:
Start: 12/29/20 End: 05/31/26 Due: 05/31/27

Study to Determine the Safety, Tolerability, Pharmacokinetics and Recommended Phase 2 Dose (RP2D) of Livmoniplimab (ABBV-151) as a Single Agent and in Combination With Budigalimab (ABBV-181) in Participants With Locally Advanced or Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03821935 Org: User:
Start: 02/21/19 End: 06/30/27 Due: 06/30/28

A Phase 1 Study of ABT-869 in Subjects With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00718380 Org: User:
Start: 09/30/08 End: 06/30/12 Due: 06/30/13

A Study to Assess Adverse Events and How Single and Multiple Ascending Doses of ABBV-903 Move Through the Body in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT05691699 Org: User:
Start: 01/03/23 End: 10/23/23 Due: 10/23/24

Juvenile Idiopathic Arthritis (JIA) Registry

Phase: N/A Priority: Normal
NCT ID: NCT00783510 Org: User:
Start: 07/11/08 End: 02/01/24 Due: 02/01/25

A Study to Evaluate Efficacy, Safety, and Tolerability of Darigabat in Participants With Panic Disorder

Phase: N/A Priority: Normal
NCT ID: NCT05941442 Org: User:
Start: 07/31/23 End: 03/31/25 Due: 03/31/26

A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01328626 Org: User:
Start: 05/23/11 End: 05/08/20 Due: 05/08/21

Study of the Safety and Efficacy of Elagolix in Women With Polycystic Ovary Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT03951077 Org: User:
Start: 08/12/19 End: 02/10/21 Due: 02/10/22

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ABT-493 and ABT-530 With and Without Ribavirin in Adults With HCV Who Failed a Prior DAA Containing Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02446717 Org: User:
Start: 04/30/15 End: 01/31/17 Due: 01/31/18

Cariprazine Pediatric ASD PK Study

Phase: N/A Priority: Normal
NCT ID: NCT04382885 Org: User:
Start: 06/26/20 End: 12/10/21 Due: 12/10/22